November Blog
US$ 24.51
glp-1 obesity drug news oct 21 2025 Weight Loss Enforcement in 2025: State Attorneys General Step into a Growing Regulatory Gap GLP-1s for Weight Loss: What
Description
doi:10.1111/dom.12926
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
Limited competition and supply constraints exacerbate cost pressures, impacting health plans and patients
Maria Carrillo, chief science officer and medical affairs lead for the Alzheimers Association, which was not involved with the research
Both Mounjaro and Ozempic are FDA-approved to treat type 2 diabetes but used off-label to treat obesity, explains Dr
Similarly, individuals who have a history of gastrointestinal issues may want to avoid Mounjaro. Smith added that you should talk with your doctor about your medical history to determine which drug may be better for you
